PL4240837T3 - Laktamowe modyfikowane wektory wirusowe związane z adenozami - Google Patents
Laktamowe modyfikowane wektory wirusowe związane z adenozamiInfo
- Publication number
- PL4240837T3 PL4240837T3 PL21805954.1T PL21805954T PL4240837T3 PL 4240837 T3 PL4240837 T3 PL 4240837T3 PL 21805954 T PL21805954 T PL 21805954T PL 4240837 T3 PL4240837 T3 PL 4240837T3
- Authority
- PL
- Poland
- Prior art keywords
- lactam
- associated virus
- virus vectors
- modified adeno
- adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicinal Chemistry (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2020/081396 WO2021089856A1 (en) | 2019-11-08 | 2020-11-06 | Modified adeno-associated virus vectors and delivery thereof into the central nervous system |
| US202163187648P | 2021-05-12 | 2021-05-12 | |
| EP21305633 | 2021-05-12 | ||
| PCT/EP2021/080832 WO2022096681A1 (en) | 2020-11-06 | 2021-11-05 | Lactam-modified adeno-associated virus vectors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4240837T3 true PL4240837T3 (pl) | 2026-04-13 |
Family
ID=81458347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21805954.1T PL4240837T3 (pl) | 2020-11-06 | 2021-11-05 | Laktamowe modyfikowane wektory wirusowe związane z adenozami |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4240837B1 (pl) |
| JP (1) | JP2023548217A (pl) |
| KR (1) | KR20230107584A (pl) |
| AU (1) | AU2021374832A1 (pl) |
| CA (1) | CA3196597A1 (pl) |
| ES (1) | ES3063368T3 (pl) |
| IL (1) | IL302444A (pl) |
| PL (1) | PL4240837T3 (pl) |
| WO (1) | WO2022096681A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116802279A (zh) | 2020-11-06 | 2023-09-22 | 科亚韦治疗公司 | 内酰胺修饰的腺相关病毒载体 |
| WO2024165721A1 (en) | 2023-02-10 | 2024-08-15 | Coave Therapeutics | Squaramide-modified adeno-associated virus vectors |
| WO2025051994A1 (en) | 2023-09-07 | 2025-03-13 | Coave Therapeutics | Ionizable lipid nanoparticles |
| WO2025114520A1 (en) | 2023-12-01 | 2025-06-05 | Coave Therapeutics | Ionizable lipid nanoparticles |
| WO2026037731A1 (en) | 2024-08-12 | 2026-02-19 | Coave Therapeutics | Squaramide-modified viral vectors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1202081C (zh) * | 1998-06-25 | 2005-05-18 | 布里斯托尔-迈尔斯斯奎布公司 | 脒基和胍基β－丙内酰胺类胰蛋白酶抑制剂 |
| US6335324B1 (en) * | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
| US20040147502A1 (en) * | 2002-12-17 | 2004-07-29 | Bisacchi Gregory S. | Beta lactam compounds and their use as inhibitors of tryptase |
| US20040180855A1 (en) * | 2003-02-19 | 2004-09-16 | Schumacher William A. | Methods of treating thrombosis with reduced risk of increased bleeding times |
| AU2010339456A1 (en) * | 2009-12-30 | 2012-07-05 | Celgene Avilomics Research, Inc. | Ligand-directed covalent modification of protein |
| EP3469073B1 (en) * | 2016-06-09 | 2024-01-10 | Centre National de la Recherche Scientifique (CNRS) | Raav with chemically modified capsid |
| IL289489B2 (en) | 2019-07-11 | 2025-06-01 | Centre Nat Rech Scient | Chemically-modified adeno-associated virus |
| EP4055151A1 (en) | 2019-11-08 | 2022-09-14 | Coave Therapeutics | Modified adeno-associated virus vectors and delivery thereof into the central nervous system |
-
2021
- 2021-11-05 KR KR1020237016607A patent/KR20230107584A/ko active Pending
- 2021-11-05 ES ES21805954T patent/ES3063368T3/es active Active
- 2021-11-05 AU AU2021374832A patent/AU2021374832A1/en active Pending
- 2021-11-05 IL IL302444A patent/IL302444A/en unknown
- 2021-11-05 PL PL21805954.1T patent/PL4240837T3/pl unknown
- 2021-11-05 WO PCT/EP2021/080832 patent/WO2022096681A1/en not_active Ceased
- 2021-11-05 CA CA3196597A patent/CA3196597A1/en active Pending
- 2021-11-05 JP JP2023527273A patent/JP2023548217A/ja active Pending
- 2021-11-05 EP EP21805954.1A patent/EP4240837B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES3063368T3 (en) | 2026-04-16 |
| EP4240837C0 (en) | 2026-01-28 |
| IL302444A (en) | 2023-06-01 |
| AU2021374832A9 (en) | 2024-02-08 |
| EP4240837A1 (en) | 2023-09-13 |
| KR20230107584A (ko) | 2023-07-17 |
| CA3196597A1 (en) | 2022-05-12 |
| WO2022096681A1 (en) | 2022-05-12 |
| AU2021374832A1 (en) | 2023-06-08 |
| EP4240837B1 (en) | 2026-01-28 |
| JP2023548217A (ja) | 2023-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286464A (en) | A virus of vectors related to recombinant DNA | |
| IL277666A (en) | Virus vector evasion antibody | |
| IL277664A (en) | Virus vector evasion antibody | |
| EP4061427A4 (en) | Adeno-associated viral vector variants | |
| IL276859A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
| IL286911A (en) | Recombinant adeno-associated viruses and their uses | |
| IL276860A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
| IL287214A (en) | Adeno-associated virus vector formulations and methods | |
| IL273933A (en) | AAV vectors | |
| IL276341A (en) | Methods and compositions for bypassing virus antibody vectors | |
| SG11202011145UA (en) | Liver targeting adeno-associated viral vectors | |
| GB201800903D0 (en) | Vectors | |
| IL275833A (en) | Adapted vectors of vaccinia | |
| EP3221456A4 (en) | Genome-modified recombinant adeno-associated virus vectors | |
| IL289489A (en) | A chemically modified adeno-associated virus | |
| IL288419A (en) | Recombinant viral herpes vector | |
| IL272655A (en) | Recombinant adeno-associated vectors | |
| IL299380A (en) | An improved adenovirus as a vector for gene therapy | |
| GB2590774B (en) | Vector | |
| GB202119008D0 (en) | Improved vaccinia virus vectors | |
| IL277161A (en) | Parfoxvirus vectors | |
| IL285639A (en) | Adeno-associated virus vectors for drug delivery | |
| EP3751000C0 (en) | IMPROVED ADENO-ASSOCIATED VIRAL VECTOR | |
| GB201913974D0 (en) | Vector | |
| GB201907801D0 (en) | Data-exchange between blockchains |